We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

DC District Court Sides With FDA In Alphapharma's Celexa Patent Challenge

Law360 (August 17, 2004, 12:00 AM EDT) -- A U.S. District Judge has dismissed a patent challenge to Forest Laboratories' antidepressant drug Celexa by Australian drugmaker Alphapharm Pty. Ltd., upholding a decision by the U.S. Food and Drug Administration to deny Alphapharm’s Abbreviated New Drug Application (ANDA) to market a generic version of the drug.

In his ruling, U.S. District Judge James Robertson of the U.S. District Court for the District of Columbia said the FDA had "properly refused" to accept Alphapharm's ANDA.

Robertson said in his opinion the FDA's role in reviewing patent...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.